Literature DB >> 25561023

Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Igor F Tsigelny1, Yuriy Sharikov1, Valentina L Kouznetsova1, Jerry P Greenberg1, Wolf Wrasidlo1, Cassia Overk1, Tania Gonzalez1, Margarita Trejo1, Brian Spencer1, Kori Kosberg1, Eliezer Masliah1.   

Abstract

Parkinson's disease (PD) is associated with the formation of toxic α-synuclein oligomers that can penetrate the cell membrane. Familial forms of PD are caused by the point mutations A53T, A30P, E46K, and H50Q. Artificial point mutations E35K and E57K also increase oligomerization and pore formation. We generated structural conformations of α-synuclein and the above-mentioned mutants using molecular dynamics. We elucidated four main regions in these conformers contacting the membrane and found that the region including residues 39-45 (Zone2) may have maximum membrane penetration. E57K mutant had the highest rate of interaction with the membrane, followed by A53T, E46K, and E35K mutants and wild type (wt) α-synuclein. The mutant A30P had the smallest percentage of conformers that contact the membrane by Zone 2 than all other mutants and wt α-synuclein. These results were confirmed experimentally in vitro. We identified the key amino acids that can interact with the membrane (Y38, E62, and N65 (first hydrophilic layer); E104, E105, and D115 (second hydrophilic layer), and V15 and V26 (central hydrophobic layer)) and the residues that are involved in the interprotein contacts (L38, V48, V49, Q62, and T64). Understanding the molecular interactions of α-synuclein mutants is important for the design of compounds blocking the formation of toxic oligomers.

Entities:  

Keywords:  membrane interactions; molecular dynamics; neurodegeneration; oligomers; α-Synuclein; α-synuclein mutants

Mesh:

Substances:

Year:  2015        PMID: 25561023      PMCID: PMC4944825          DOI: 10.1021/cn500332w

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  60 in total

1.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

2.  MAPAS: a tool for predicting membrane-contacting protein surfaces.

Authors:  Yuriy Sharikov; Ross C Walker; Jerry Greenberg; Valentina Kouznetsova; Sanjay K Nigam; Mark A Miller; Eliezer Masliah; Igor F Tsigelny
Journal:  Nat Methods       Date:  2008-02       Impact factor: 28.547

3.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

4.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

5.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

6.  Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence.

Authors:  Allan Chris M Ferreon; Yann Gambin; Edward A Lemke; Ashok A Deniz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

7.  Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.

Authors:  Hyun-Jung Koo; Min Yeong Choi; Hana Im
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

8.  In-cell NMR characterization of the secondary structure populations of a disordered conformation of α-synuclein within E. coli cells.

Authors:  Christopher A Waudby; Carlo Camilloni; Anthony W P Fitzpatrick; Lisa D Cabrita; Christopher M Dobson; Michele Vendruscolo; John Christodoulou
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

9.  Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.

Authors:  Igor F Tsigelny; Leslie Crews; Paula Desplats; Gideon M Shaked; Yuriy Sharikov; Hideya Mizuno; Brian Spencer; Edward Rockenstein; Margarita Trejo; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

10.  Wildtype and A30P mutant alpha-synuclein form different fibril structures.

Authors:  Søren Bang Nielsen; Francesca Macchi; Samuele Raccosta; Annette Eva Langkilde; Lise Giehm; Anders Kyrsting; Anna Sigrid Pii Svane; Mauro Manno; Gunna Christiansen; Niels Christian Nielsen; Lene Oddershede; Bente Vestergaard; Daniel Erik Otzen
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more
  15 in total

Review 1.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

2.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

3.  FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.

Authors:  Xiu-Qi Bao; Xiao-Liang Wang; Dan Zhang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

4.  A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease.

Authors:  Wolfgang Wrasidlo; Igor F Tsigelny; Diana L Price; Garima Dutta; Edward Rockenstein; Thomas C Schwarz; Karin Ledolter; Douglas Bonhaus; Amy Paulino; Simona Eleuteri; Åge A Skjevik; Valentina L Kouznetsova; Brian Spencer; Paula Desplats; Tania Gonzalez-Ruelas; Margarita Trejo-Morales; Cassia R Overk; Stefan Winter; Chunni Zhu; Marie-Francoise Chesselet; Dieter Meier; Herbert Moessler; Robert Konrat; Eliezer Masliah
Journal:  Brain       Date:  2016-09-27       Impact factor: 13.501

5.  Bibenzyl compound 20c protects against endoplasmic reticulum stress in tunicamycin-treated PC12 cells in vitro.

Authors:  Zheng Mou; Yu-He Yuan; Yu-Xia Lou; Yang Heng; Ju-Yang Huang; Cong-Yuan Xia; Yan Gao; Cheng-Gen Zhu; Shi-Feng Chu; Piao Luo; Jian-Gong Shi; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2016-09-12       Impact factor: 6.150

6.  Effects of pH on an IDP conformational ensemble explored by molecular dynamics simulation.

Authors:  Richard J Lindsay; Rachael A Mansbach; S Gnanakaran; Tongye Shen
Journal:  Biophys Chem       Date:  2021-01-26       Impact factor: 2.352

Review 7.  α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques.

Authors:  Nicolò Bisi; Lucia Feni; Kaliroi Peqini; Helena Pérez-Peña; Sandrine Ongeri; Stefano Pieraccini; Sara Pellegrino
Journal:  Front Chem       Date:  2021-07-07       Impact factor: 5.221

8.  The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication.

Authors:  Irum Javaid Siddiqui; Nashaiman Pervaiz; Amir Ali Abbasi
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

Review 9.  Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy.

Authors:  An Cheng; Wenbin Jia; Ichiro Kawahata; Kohji Fukunaga
Journal:  Biomedicines       Date:  2021-05-17

10.  Membrane binding, internalization, and sorting of alpha-synuclein in the cell.

Authors:  Caterina Masaracchia; Marilena Hnida; Ellen Gerhardt; Tomás Lopes da Fonseca; Anna Villar-Pique; Tiago Branco; Markus A Stahlberg; Camin Dean; Claudio O Fernández; Ira Milosevic; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2018-08-14       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.